In several cancers, such as hepatocellular carcinoma and non‐small cell lung cancer, the expression of EVA1A is low in carcinoma tissues, and EVA1A can inhibit tumour cell growth through autophagy and apoptosis.9, 10. Here, EVA1A is linked to hepatocellular carcinoma.